Neuropeptide Y1 receptor vasoconstriction in exercising canine skeletal muscles

Journal of Applied Physiology

Volumn 99, Issue 6, 2005, Pages 2115-2120

  Buckwalter, John B ^a   Hamann, Jason J ^a   Clifford, Philip S ^a  

^a CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Autonomic nervous system; Blood flow; Sympathetic nervous system

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y [31 LEUCINE 34 PROLINE]; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; NORADRENALIN; PRAZOSIN; RAUWOLSCINE; ARGININE; DRUG DERIVATIVE; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y Y1 RECEPTOR; NEUROPEPTIDE Y-Y1 RECEPTOR;

ADRENERGIC RECEPTOR BLOCKING; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD VESSEL TONE; BOLUS INJECTION; CARDIOVASCULAR AUTOREGULATION; CONTROLLED STUDY; DOG; DRUG INFUSION; EXERCISE; FEMORAL ARTERY; MUSCLE BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; TREADMILL EXERCISE; VASOCONSTRICTION; VASODILATATION; ANIMAL; BLOOD FLOW VELOCITY; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; METHODOLOGY; MOTOR ACTIVITY; PHYSIOLOGY; SKELETAL MUSCLE; VASCULARIZATION;

ANIMALS; ARGININE; BLOOD FLOW VELOCITY; DOGS; EXERTION; MOTOR ACTIVITY; MUSCLE, SKELETAL; PHYSICAL CONDITIONING, ANIMAL; RECEPTORS, NEUROPEPTIDE Y; VASOCONSTRICTION;

EID: 28044443128     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.00427.2005     Document Type: Article

References (42)

1. Berglund MM, Hipskind PA, and Gehlert DR. Recent developments in our understanding of the physiological role of PP-fold peptide receptor subtypes. Exp Biol Med (Maywood) 228: 217-244, 2003.
2. Buckwalter JB and Clifford PS. The paradox of sympathetic vasoconstriction in exercising skeletal muscle. Exerc Sport Sci Rev 29: 159-163, 2001.
3. Buckwalter JB, Naik JS, Valic Z, and Clifford PS. Exercise attenuates α-adrenergic receptor responsiveness in skeletal muscle vasculature. J Appl Physiol 90: 172-178, 2001.
4. Buckwalter JB and Clifford PS. α-Adrenergic vasoconstriction in active skeletal muscles during dynamic exercise. Am J Physiol Heart Circ Physiol 277: H33-H39, 1999.
5. Buckwalter JB and Clifford PS. Autonomic influence on skeletal muscle blood flow at the onset of dynamic exercise. Am J Physiol Heart Circ Physiol 277: H1872-H1877, 1999.
6. Buckwalter JB, Hamann JJ, and Clifford PS. Vasoconstriction in active skeletal muscles: a potential role for P2X purinergic receptors? J Appl Physiol 95: 953-959, 2003.
7. Buckwalter JB, Hamann JJ, Kluess HL, and Clifford PS. Vasoconstriction in active skeletal muscles: a potential role for neuropeptide Y? Am J Physiol Heart Circ Physiol 287: H144-H149, 2004.
8. Buckwalter JB, Mueller PJ, and Clifford PS. Sympathetic vasoconstriction in active skeletal muscles during dynamic exercise. J Appl Physiol 83: 1575-1580, 1997.
9. Buckwalter JB, Ruble SB, Mueller PJ, and Clifford PS. Skeletal muscle vasodilation at the onset of exercise. J Appl Physiol 85: 1649-1654, 1998.
10. Buckwalter JB, Taylor JC, Hamann JJ, and Clifford PS. Do P2X purinergic receptors regulate skeletal muscle blood flow during exercise? Am J Physiol Heart Circ Physiol 286: H633-H639, 2004.
11. DiCarlo SE, Chen CY, and Collins HL. Onset of exercise increases lumbar sympathetic nerve activity in rats. Med Sci Sports Exerc 28: 677-684, 1996.
12. Hajduczok G, Hade JS, Mark AL, Williams JL, and Felder RB. Central command increases sympathetic nerve activity during spontaneous locomotion in cats. Circ Res 69: 66-75, 1991.
13. Hamann JJ, Buckwalter JB, Valic Z, and Clifford PS. Sympathetic restraint of muscle blood flow at the onset of dynamic exercise. J Appl Physiol 92: 2452-2456, 2002.
14. Hill JM, Adreani CM, and Kaufman MP. Muscle reflex stimulates sympathetic postganglionic efferents innervating triceps surae muscles of cats. Am J Physiol Heart Circ Physiol 271: H38-H43, 1996.
15. 2Y- purinoceptors in the isolated perfused rat heart. Eur J Pharmacol 136: 49-54, 1987.
16. Hu Y and Dunbar JC. Regional vascular cardiac responses to systemic neuropeptide-Y in normal and diabetic rats. Peptides 18: 809-815, 1997.
17. Kennedy C, Saville VL, and Burnstock G. The contributions of noradrenaline and ATP to the responses of the rabbit central ear artery to sympathetic nerve stimulation depend on the parameters of stimulation. Eur J Pharmacol 122: 291-300, 1986.
18. Klabunde RE. Attenuation of reactive and active hyperemia by sympathetic stimulation in dog gracilis muscle. Am J Physiol Heart Circ Physiol 251: H1183-H1187, 1986.
19. Lautt WW. Resistance or conductance for expression of arterial vascular tone. Microvasc Res 37: 230-236, 1989.
20. Lundberg JM, Franco-Cereceda A, Lou YP, Modin A, and Pernow J. Differential release of classical transmitters and peptides. Adv Second Messenger Phosphoprotein Res 29: 223-234, 1994.
21. Lundberg JM, Franco-Cereceda A, Lacroix JS, and Pernow J. Neuropeptide Y and sympathetic neurotransmission. Ann NY Acad Sci 611: 166-174, 1990.
22. Lundberg JM, Martinsson A, Mensen A, Theodorsson-Norheim E, Svedenhag J, Ekblom B, and Hjemdahl P. Co-release of neuropeptide Y and catecholamines during physical exercise in man. Biochem Biophys Res Commun 133: 30-36, 1985.
23. Lundberg JM and Modin A. Inhibition of sympathetic vasoconstriction in pigs in vivo by neuropeptide Y-Y1 receptor antagonist BIBP 3226. Br J Pharmacol 116: 2971-2982, 1995.
24. Mabe Y, Tatemoto K, and Huidobro-Toro JP. Neuropeptide Y induced pressor responses: activation of a non-adrenergic mechanism, potentiation by reserpine and blockade by nifedipine. Eur J Pharmacol 116: 33-39, 1985.
25. Malmstrom RE, Hokfelt T, Bjorkman JA, Nihlen C, Bystrom M, Ekstrand AJ, and Lundberg JM. Characterization and molecular cloning of vascular neuropeptide Y receptor subtypes in pig and dog. Regul Pept 75-76: 55-70, 1998.
26. Marshall RJ, Schirger A, and Shepherd JT. Blood pressure during supine exercise idiopathic orthostatic hypotension. Circulation 24: 76-81, 1961.
27. Meier MA and Long DM. Carotid artery loop for repeated catheterization of the left verntricle in dogs. Surgery 70: 797-799, 1971.
28. Nilsson T, Hrafnkelsdottier T, Edvinsson L, Jern S, Erlinge D, and Wall U. Forearm blood flow responses to neuropeptide Y, noradrenaline and adenosine 5-triphosphate in hypertensive and normotensive subjects. I Blood Press 9: 126-131, 2000.
29. O'Brien DJ, Chapman WH, Rudd FV, and McRoberts JW. Carotid artery loop method of blood pressure measurement in the dog. J Appl Physiol 30: 161-163, 1971.
30. O'Hagan KP, Bell LB, Mittelstadt SW, and Clifford PS. Effect of dynamic exercise on renal sympathetic nerve activity in conscious rabbits. J Appl Physiol 74: 2099-2104, 1993.
31. O'Leary DS, Robinson ED, and Butler JL. Is active skeletal muscle functionally vasoconstricted during dynamic exercise in conscious dogs? Am J Physiol Regul Integr Comp Physiol 272: R386-R391, 1997.
32. Pernow J, Kahan T, Hjemdahl P, and Lundberg JM. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle. Acta Physiol Scand 132: 43-50, 1988.
33. Pernow J, Lundberg JM, Kaijser L, Hjemdahl P, Theodorsson-Norheim E, Martinsson A, and Pernow B. Plasma neuropeptide Y-like immunoreactiviity and catecholamines during various degrees of sympathetic activation in man. Clin Physiol 6: 561-578, 1986.
34. Pernow J, Ohlen A, Hokfelt T, Nilsson O, and Lundberg JM. Neuropeptide Y: presence in perivascular noradrenergic neurons and vasoconstrictor effects on skeletal muscle blood vessels in experimental animals and man. Regul Pept 19: 313-324, 1987.
35. Remensnyder JP, Mitchell JH, and Sarnoff SJ. Functional sympatholysis during muscular activity. Circ Res 11: 370-380, 1962.
36. 2 adrenergic vasoconstriction is blunted in contracting human muscle. J Physiol 547: 971-976, 2003.
37. Rowell LB. Human Cardiovascular Control. New York: Oxford Universtiy Press, 1993.
38. 1 adrenergic blood pressure responses in vivo. Am J Physiol Heart Circ Physiol 275: H760-H766, 1998.
39. Ruble SB, Valic Z, Buckwalter JB, Tschakovsky ME, and Clifford PS. Attenuated vascular responsiveness to norepinephrine release during dynamic exercise in dogs. J Physiol 541: 637-644, 2002.
40. Tschakovsky ME, Sujirattanawimol K, Ruble SB, Valic Z, and Joyner MJ. Is sympathetic neural vasoconstriction blunted in the vascular bed of exercising human muscle? J Physiol 541: 623-635, 2002.
41. Wahlestedt C, Edvinsson L, Ekblad E, and Hakanson R. Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action. J Pharmacol Exp Ther 234: 735-741, 1985.
42. Wahlestedt C, Yanaihara N, and Hakanson R. Evidence for different pre- and post-junctional receptors for neuropeptide Y and related peptides. Regul Pept 13: 307-318, 1986.